- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01382771
Intraarticular Lumbar Joint Corticosteroid Injection(s) as a Treatment of Chronic Low Back Pain in a Selected Population
A Randomized, Double-Blind, Placebo Controlled Perspective Study of Intraarticular Lumbar Zygapophysial Joint Corticosteroid Injection(s) as a Treatment of Chronic Low Back Pain in a Selected Population
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Subjects will have failed conservative treatment, including, but not limited to oral medications, physical therapy, chiropractic treatment, and/or alternative medicine. They will be evaluated by a spine specialist in the Spine Division of the Department of Orthopaedics and will be schedule for a medial branch block as standard of care. As part of usual and standard care, patients will undergo lumbar medial branch blocks for diagnosis of zygapophysial joint pain.
Patients who obtain ≥ to 80% relief of their index pain with a first set of lumbar medial branch blocks will be offered the opportunity for possible inclusion in the study if they are scheduled to receive a second medial branch block. The definition of a positive response to MBB's is an 80% reduction in pain (by change in NPR scores or estimated patient improvement) AND the restoration of the ability to perform at least one previously painful posture, movement, or activity without increase in pain, during the anesthetic phase of the blocks. If subjects are unable to render NPR scores or percentage estimate of improvement, then a 5 point global perception of effect tool will be used.
Studietype
Registrering (Faktiske)
Fase
- Tidlig fase 1
Kontakter og plasseringer
Studiesteder
-
-
Florida
-
Gainesville, Florida, Forente stater, 32607
- UF & Shands Orthopaedics and Sports Medicine Institute
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Low back pain episode greater than six months in duration
- NPR pain scale score three day average and present pain of at least four/ten at baseline (index pain)
- Previous medial branch block providing >80% pain relief for current painful episode
- Subject must be scheduled to undergo a second medial branch block for their back pain
Exclusion Criteria:
- Litigation
- Those seeking new or increased long-term remuneration
- Leg pain greater than back pain
- Radicular pain or evidence of neurological compromise in the lower limbs
- Those unable to read English and complete the assessment instruments
- Systemic inflammatory arthritis (e.g. rheumatoid, lupus)
- Addictive behavior, severe clinical depression or psychotic features. The subjects will be identified at the sole discretion of the PI who per the current standard of care will consent the potential subjects to the study
- Significant lower extremity pathology that affects gait
- Sustained cervical or thoracic pain that is present at a level >3/10 on NPR
- Possible pregnancy or other reason that precludes the use of fluoroscopy
- Significant scoliosis
- Radicular/neurological deficits or focal disc herniation and/or stenosis, with correlating radicular symptoms
- Contra-indication to corticosteroid, including known allergies or sensitivities
- History of prior epidural spinal injections relieving their current pain, or prior lumbar surgery.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Firemannsrom
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Aktiv komparator: Intra-articular corticosteroid injection
Intra-articular corticosteroid injection in conjunction with confirmatory anesthetic medial branch blocks
|
Intra-articular injection of 0.5 cc triamcinolone acetonide (40 mg/cc) within each joint
|
Placebo komparator: Intra-articular saline injection
Intra-articular saline injections with confirmatory anesthetic medial branch blocks
|
Intra-articular injection of 0.5 cc normal saline in each joint
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Numeric Pain Rating (NPR) or patient estimation of improvement, >80% pain reduction
Tidsramme: Hourly for 6 hours post injections
|
A positive response is defined as are ≥ 80% reduction in pain (by change in NPR scores or estimated patient improvement) AND the restoration of the ability to perform at least one previously painful posture, movement, or activity without increase in pain, during the anesthetic phase of the blocks.
|
Hourly for 6 hours post injections
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Numeric Pain Rating (NPR) Daily diary
Tidsramme: reviewed at 6 weeks, 3 months, 6 months, 12 months follow-up
|
The patient will be instructed to maintain a pain diary that records the degree and duration of any relief.
|
reviewed at 6 weeks, 3 months, 6 months, 12 months follow-up
|
Oswestry Disability Index (ODI)
Tidsramme: 6 weeks, 3 months, 6 months, 12 months
|
Patient will complete ODI at the follow-up intervals.
|
6 weeks, 3 months, 6 months, 12 months
|
Standard Form 36 (SF-36), General Health Survey
Tidsramme: 6 weeks, 3 months, 6 months, 12 months
|
Patient will complete the SF-36 at the follow-up intervals.
The SF-36 is a self-administered, generic, general health survey consisting of 36 questions.
The questions focus on the functional health and well being of the subject completing the form.
|
6 weeks, 3 months, 6 months, 12 months
|
Daily Work History Log
Tidsramme: reviewed at the 6 weeks, 3months, 6 months, 12 months follow-up
|
Patient will keep a Work History Log during participation.
The Log should indicate the daily work activities of the subject.
|
reviewed at the 6 weeks, 3months, 6 months, 12 months follow-up
|
Daily Analgesic Use Log
Tidsramme: reviewed at 6 weeks, 3 months, 6 months, 12 months
|
Patient will keep a Daily Analgesic Use Log during participation.
|
reviewed at 6 weeks, 3 months, 6 months, 12 months
|
Ancillary Treatment Log
Tidsramme: reviewed at 6 weeks, 3 months, 6 months, 12 months follow-up
|
Patient will keep an Ancillary Treatment Log during participation.
This log will indicate any outside medical care, additional medial branch blocks or radiofrequency neurotomy treatments.
|
reviewed at 6 weeks, 3 months, 6 months, 12 months follow-up
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: D. J. Kennedy, M.D., UF Department of Orthopaedics and Rehabilitation
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 319-2010
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Smerte i korsryggen
-
Otsuka Pharmaceutical Co., Ltd.Aktiv, ikke rekrutterendeHyper-low-density Lipoprotein (LDL) KolesterolemiJapan
-
Bozok UniversityFullført
-
Health Services Academy, Islamabad, PakistanUkjentmHelse | Gjeninnleggelse | Teach-back kommunikasjonPakistan
-
Rush University Medical CenterFullførtPasientutdanning | Teach-back kommunikasjon | Etter besøksinstruksjoner | PasientforståelseForente stater
-
Medical College of WisconsinChildren's Hospital and Health System Foundation, WisconsinAktiv, ikke rekrutterendeSimulering av fysisk sykdom | Trakeostomikomplikasjon | Teach-back kommunikasjonForente stater
-
Otsuka Pharmaceutical Co., Ltd.FullførtHyper-low-density Lipoprotein (LDL) KolesterolemiJapan
-
Marmara UniversityAktiv, ikke rekrutterendeTeach-back kommunikasjonTyrkia
-
Jordan Collaborating Cardiology GroupThe Cardiovascular Academy Group of the JCS; The Jordan Cardiac Society... og andre samarbeidspartnereAvsluttetAterosklerotisk kardiovaskulær risiko | Low-density-lipoprotein (LDL) kolesterolJordan
-
University of ValenciaFullført
-
Nina HermansUniversity Hospital, AntwerpRekrutteringLow-density-lipoprotein-type [LDL] HyperlipoproteinemiBelgia